Core Viewpoint - BenQ Hospital (02581.HK) plans to globally offer 67 million shares, with a maximum offer price of HKD 11.68 per share, aiming to raise approximately HKD 704 million for various expansion and operational purposes [1] Group 1: Share Offering Details - The global offering consists of 6.7 million shares for Hong Kong and 60.3 million shares for international investors [1] - The subscription period is set from December 12 to December 17, with an entry fee of approximately HKD 5,898.90 for a board lot of 500 shares [1] - The expected net proceeds from the offering are HKD 626 million, which will be used for hospital expansion, potential investments and acquisitions, upgrading to a "smart hospital," and general working capital [1] Group 2: Financial Performance - The company's net profit for the fiscal years ending June 30, 2023, 2024, and the first half of 2025 is projected to be CNY 167 million, CNY 109 million, and CNY 48.704 million, reflecting year-on-year changes of 86.99%, -34.95%, and -23.18% respectively [2] Group 3: Strategic Partnerships and Market Position - The company has secured cornerstone investors including He Rong Technology Co., Ltd., He Fu (China) Medical Technology Co., Ltd., and Suzhou Zhanxing Investment Fund Partnership [1] - BenQ Hospital draws on advanced hospital management practices from Taiwan and operates as a private for-profit general hospital group in mainland China [1] Group 4: Listing Information - The company is expected to be listed on the main board by December 22, 2025, with China International Capital Corporation Hong Kong Securities Limited and Citigroup Global Markets Asia Limited acting as joint sponsors [1]
明基医院(02581.HK) 12月12日—12月17日招股